Preliminary safety and clinical activity of atezolizumab combined with cobimetinib and vemurafenib in BRAF V600-mutant metastatic melanoma
| Autor: | Manish R. Patel, G. Mwawasi, Rene Gonzalez, Ryan J. Sullivan, Edward Cha, Marcus Ballinger, Karl D. Lewis, N. Richie, J. R. Infante, Jeffrey Wallin, F.S. Hodi, Omid Hamid, Patrick Hwu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Cobimetinib Metastatic melanoma business.industry Mutant Hematology 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Oncology chemistry Atezolizumab 030220 oncology & carcinogenesis Cancer research medicine Vemurafenib business medicine.drug |
| Zdroj: | Annals of Oncology. 27:vi380 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdw379.05 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|